THRIVE (NICOTINE POLACRILEX) — FDA Approval ANDA077658 (GLAXOSMITHKLINE CONS)
THRIVE (NICOTINE POLACRILEX) — FDA Approval ANDA077658 (GLAXOSMITHKLINE CONS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: THRIVE; Active ingredients: NICOTINE POLACRILEX; Application number: ANDA077658.
| Brand name | THRIVE |
|---|---|
| Active ingredients | NICOTINE POLACRILEX |
| Application number | ANDA077658 |
| Sponsor | GLAXOSMITHKLINE CONS |
| Dosage form | GUM, CHEWING |
| Route | BUCCAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20070619 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →